Skip to main content
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1973 Feb;36(1):27–29. doi: 10.1136/jnnp.36.1.27

Brocresine in Parkinson's disease

Action of a peripheral and central decarboxylase inhibitor in potentiating levodopa

Patricia M Howse 1, W B Matthews 1
PMCID: PMC494271  PMID: 4570903

Abstract

Brocresine, an aromatic L-amino acid decarboxylase inhibitor with both a peripheral and central action was shown to potentiate the therapeutic effect of levodopa in Parkinson's disease. The search for useful decarboxylase inhibitors therefore need not be limited to agents that do not pass the blood/brain barrier.

Full text

PDF
27

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BERTLER A., CARLSSON A., ROSENGREN E. A method for the fluorimetric determination of adrenaline and noradrenaline in tissues. Acta Physiol Scand. 1958 Dec 15;44(3-4):273–292. doi: 10.1111/j.1748-1716.1958.tb01627.x. [DOI] [PubMed] [Google Scholar]
  2. Bartholini G., Pletscher A. Cerebral accumulation and metabolism of C14-dopa after selective inhibition of peripheral decarboxylase. J Pharmacol Exp Ther. 1968 May;161(1):14–20. [PubMed] [Google Scholar]
  3. CARLSSON A., WALDECK B. A fluorimetric method for the determination of dopamine (3-hydroxytyramine). Acta Physiol Scand. 1958 Dec 15;44(3-4):293–298. doi: 10.1111/j.1748-1716.1958.tb01628.x. [DOI] [PubMed] [Google Scholar]
  4. Ellenbogen L., Stubbs C. S., Jr, Markley E., Taylor R. J., Jr Assay and rapid disappearance of brocresine activity in blood. Biochem Pharmacol. 1971 Jul;20(7):1501–1506. [PubMed] [Google Scholar]
  5. Gauthier G., de Ajuriaguerra J., Simona B., Constantinidis J., Eisenring J. J., Krassoievitch M., Yanniotis G., Tissot R. Thérapeutique du syndrome parkinsonien par la L-Dopa associée à des inhibiteurs de la décarboxylase. I. Rev Neurol (Paris) 1970 Nov;123(5):297–319. [PubMed] [Google Scholar]
  6. HANSSON E., FLEMING R. M., CLARK W. G. EFFECT OF SOME BENZYLHYDRAZINES AND BENZYLOXYAMINES ON DOPA AND 5-HYDROXYTRYPTOPHAN DECARBOXYLASE IN VIVO. Int J Neuropharmacol. 1964 May;3:177–188. doi: 10.1016/0028-3908(64)90006-1. [DOI] [PubMed] [Google Scholar]
  7. Siegfried J. Deux ans d'expérience avec la L-DOPA associée à un inhibiteur de la décarboxylase. Rev Neurol (Paris) 1970 Apr;122(4):243–248. [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES